Description
by Everest Pharmaceuticals is a medication containing Selpercatinib, a potent RET inhibitor used in the treatment of certain cancers driven by RET gene alterations. Here’s an overview of its key features:
-
: Each tablet or capsule contains 40 mg of Selpercatinib.
-
: Used for treating non-small cell lung cancer (NSCLC) and advanced thyroid cancer, particularly in cases with RET fusion-positive genes. It is also indicated for advanced medullary thyroid cancer (MTC) in patients with RET mutations134.
-
: Selpercatinib works by inhibiting the RET tyrosine kinase, which is involved in cancer cell growth and proliferation. By blocking this pathway, it slows or stops the spread of cancer cells23.
-
: Taken orally twice daily (every 12 hours), with or without food3.
-
: Common side effects include dry mouth, diarrhea, constipation, headache, cough, swelling of ankles/feet, nausea, vomiting, and fatigue3.
-
: Everest Pharmaceuticals Ltd., Bangladesh.
-
: Available in bottles containing 30 capsules or tablets.







Reviews
There are no reviews yet.